Lipum at its Annual General Meeting on May 10, Carl-Johan Spak was elected as a new board member of Lipum. Carl-Johan is a senior advisor at Flerie Invest and will contribute with useful knowledge, his experience from the pharmaceutical industry and previous board assignments. BioStock talked to Carl-Johan Spak about his professional background and his expectations for the role in Lipum.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.7 SEK | -0.57% |
|
+8.75% | +33.44% |
06-18 | Lipum AB Completes Multiple Dose Part of the Phase I Clinical Study | CI |
05-28 | Lipum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+33.44% | 17.61M | |
+1.87% | 93.91B | |
-1.32% | 38.4B | |
-13.44% | 32.61B | |
+74.65% | 28.2B | |
-13.11% | 15.91B | |
+0.68% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B |
- Stock Market
- Equities
- LIPUM Stock
- News Lipum AB
- Lipum Elects Carl-Johan Spak as New Board Member